As of 2026-04-09, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (75.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.02 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -230.6%.
The range of the Relative Valuation is (69.62) - (78.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 22.9x | 20.6x |
| Forward P/E multiples | 18.3x - 21.6x | 21.1x |
| Fair Price | (69.62) - (78.63) | (75.76) |
| Upside | -220.0% - -235.5% | -230.6% |
| Date | P/E |
| 2026-03-02 | -15.97 |
| 2026-02-27 | -15.96 |
| 2026-02-26 | -15.95 |
| 2026-02-25 | -15.95 |
| 2026-02-24 | -15.94 |
| 2026-02-23 | -15.94 |
| 2026-02-20 | -15.94 |
| 2026-02-19 | -15.91 |
| 2026-02-18 | -15.89 |
| 2026-02-17 | -15.92 |
| 2026-02-13 | -15.89 |
| 2026-02-12 | -15.91 |
| 2026-02-11 | -15.89 |
| 2026-02-10 | -15.89 |
| 2026-02-09 | -15.90 |
| 2026-02-06 | -15.88 |
| 2026-02-05 | -15.87 |
| 2026-02-04 | -15.90 |
| 2026-02-03 | -15.89 |
| 2026-02-02 | -15.87 |
| 2026-01-30 | -15.87 |
| 2026-01-29 | -15.86 |
| 2026-01-28 | -15.87 |
| 2026-01-27 | -15.86 |
| 2026-01-26 | -15.86 |
| 2026-01-23 | -15.86 |
| 2026-01-22 | -15.86 |
| 2026-01-21 | -15.86 |
| 2026-01-20 | -15.84 |
| 2026-01-16 | -9.66 |
| 2026-01-15 | -8.86 |
| 2026-01-14 | -9.56 |
| 2026-01-13 | -9.37 |
| 2026-01-12 | -9.47 |
| 2026-01-09 | -9.25 |